Low — 0 expert voices, 0 claims in the Synthos KB; call rests entirely on fundamentals + quant
Position sizing
If owned at all: small (~1–2%), as a deep-value / income sleeve holding, not a core compounder
Next catalyst
2026-08-26 Q3 FY26 earnings (Street EPS $0.66)
Single biggest risk
Secular decline of the PC + printing franchises (flat units, eroding supplies) with a levered, negative-equity balance sheet
One-line thesis. HP is a cheap, cash-generative, high-dividend mature hardware and printing business trading at ~8× earnings — the debate is not quality (it isn't a great business) but whether ~$2.8–3.0B of annual free cash flow returned via buybacks and a 5.4% dividend is enough to offset a slowly shrinking core; a Watch because the value is real but the growth and the balance sheet are not.
◆ Synthos call — HoldHPQ is a solid business largely reflected at ~$24 — fine to keep, no reason to chase; it gets interesting again below ~$20.
Downside Risk (lower = safer)
6/10 · High
Cheap (8× EPS, 6.6× EV/EBITDA) & big FCF — but negative equity, 1.5× net-debt/EBITDA, beta 1.18, −46% max drawdown, secular PC/print decline.
Growth Quality
3/10 · Low
~2% forward revenue CAGR; EPS growth is mostly buyback, not the business; thin 20% gross margin; flat units.
Exponential Potential
1/10 · Low
Ex-growth mature hardware/print; TAM shrinking, not expanding — this is a cash-return story, not an exponential.
⚖ Reverse-DCF cross-checkMarket-implied growth ≈ -3%/yrTo justify today’s $22, earnings would have to compound roughly -3% a year for 10 years (9% discount rate). Analysts forecast ~-1%/yr, so the market is pricing in about what the Street expects.What do the 5 tiers mean? (Core · Tactical · Watch · Hold · Avoid)
Buy — CoreOwn it as a foundation — start or add now, size it for years, let dips be gifts.
Buy — TacticalGood price + confirmed trend + a defined exit — buy the setup, not a marriage.
WatchWe want the business, just not at this price/setup — act only when the listed trigger hits.
HoldFine to keep if you own it — no reason to buy more; new money does better elsewhere.
AvoidDon't own it — the problem is the business or the expectations, so a cheaper price won't fix it.
In plain English
HP makes laptops, desktops, and printers (plus the ink and toner that go in them). It's the same HP whose printers and PCs you've seen for decades. It is a big, steady, profitable business — but it is barely growing, and PCs and printing are slowly shrinking markets.
The stock is cheap: you pay about $8 for every $1 of annual profit (a fast-growing tech name can cost $30–50), and it pays a fat ~5.4% dividend. So why not just buy it? Because cheap can stay cheap: the business isn't expanding, the company owes more than it owns on paper (years of buybacks pushed its book value negative), and the stock has actually fallen 14% over the past year while the market rose ~21%.
Our verdict is Watch — not "buy," not "avoid." It's a decent income/value idea for someone who wants cash back, but it is not a wealth-builder.
Here's what our three scores mean in everyday terms:
Downside Risk 6/10 (a bit elevated). It's cheap, which cushions you, but it carries real debt, has negative book equity, and its stock swings more than the market and has dropped 46% from its peak before.
Growth Quality 3/10 (weak). The business grows about 2% a year; most of the per-share "growth" comes from buying back stock, not from selling more.
Exponential Potential 1/10 (essentially none). Its markets are flat to shrinking — this is about returning cash, not getting bigger.
The one big worry: its two businesses — PCs and printing — are slowly shrinking year after year, and it's carrying debt with a negative net worth on the books, so there's little room for a stumble.
Solid = price · dashed = 50-day average · dotted = 200-day average · amber = 52-week high/low. Price above both averages is an uptrend.
Bollinger Bands 20-day average ± 2 standard deviations
The shaded band widens when the stock gets more volatile. Riding the upper edge = strong momentum (sometimes stretched); the lower edge = weak / potentially oversold.
Blue crossing above amber (bars flip green) = momentum turning up; below (bars red) = turning down. Bar height = the size of that gap.
Relative performance vs S&P 500 & its sector (XLK (sector)), set to 100 a year ago
Solid = HPQ · dashed = S&P 500 · dotted = XLK (sector). A rising line means it is beating that benchmark — the sector line shows whether it is a leader or laggard within its own group.
Darker bars = actual results, brighter = analyst estimates. Taller bars to the right = expected growth.
Key stats an RIA wants
Price$21.93
Market cap$20B
P/E trailing1×
P/E FY26E / FY27E7× / 7×
EV / Sales0.5×
EV / EBITDA6.6×
Gross margin20.2%
Net margin4.4%
Dividend yield5.42%
Beta1.184
52-wk range$18 – $29
RSI(14)23
50 / 200-DMA$23 / $23
12-mo return+-14% (SPY +21%)
Street target$20 ($19–$22)
Analyst grades15 Buy · 28 Hold · 8 Sell
FMP ratingB-
Next earnings2026-08-05
What the experts actually said 0 traceable claims on HPQ · showing the highest-conviction voices
Every claim reconciles to a real claim_id in the Synthos knowledge base — this is the evidence the verdict is built on, not vibes. Management (the company itself) is shown but half-weighted; one cautionary voice is included on purpose.
1. What it is
HP Inc. (NYSE: HPQ) is the personal-computing-and-printing company spun out of the old Hewlett-Packard in 2015. Fiscal year ends October 31. Two segments do essentially all the work:
Personal Systems (PCs, workstations, displays, peripherals) — the volume engine.
Printing (printer hardware plus the high-margin supplies — ink and toner — annuity).
Corporate Investments (HP Labs / incubation) is a rounding error.
The strategic story management is selling is "the Future of Work": AI PCs, edge AI, and AI-enabled printing as a refresh catalyst. That is an upgrade-cycle thesis, not a new-market thesis.
Revenue mix (FY2025, from segmentation data):
By segment: Personal Systems $38.5B (~70%) · Printing $16.7B (~30%) · Corporate Investments $0.06B. Note the mix: PS is the larger but thinner-margin segment; Printing is smaller but carries the fat supplies margin (18.3% Q2-FY26 operating margin vs 5.2% for PS).
By geography: Americas $23.5B (43%) · EMEA $18.6B (34%) · Asia-Pacific $13.2B (24%). Genuinely global, less US-concentrated than most large-cap tech.
The tension in one line: the growing segment (Personal Systems) earns thin margins, and the profit-rich segment (Printing supplies) is the one in slow secular decline.
2. The expert thesis — there is none in our KB
Honest disclosure: the Synthos knowledge base contains ZERO expert claims on HPQ (total_claims: 0, net_bullish_voices: 0). None of our tracked high-skill voices (the panel that drives conviction names like LLY) covers HP. There is no borrowed conviction to cite here, and we will not fabricate any.
What that means for this note: the verdict is entirely fundamentals- and quant-driven — the financials, the analyst estimates (FMP), the valuation math, the technicals, and management's own dated guidance. Where LLY's file cites 251 traceable claim_ids, this file cites none, because none exist. That absence is itself a signal: HP is not a name the smart-money podcast/interview ecosystem is excited about. A cheap, ex-growth hardware business rarely is. Treat the Watch verdict accordingly — it is a quant/value read, not a conviction call.
3. Synthos scores & the Bull / Base / Bear cases
The one-glance judgment — three scores, 0–10, each anchored to real metrics (not probabilities we can't honestly calibrate):
Score
0–10
The read
Downside Risk(lower = safer)
6 · Elevated-Moderate
Valuation is a genuine cushion (8× EPS, 6.6× EV/EBITDA, ~14–19% FCF yield), but negative book equity, net-debt/EBITDA 1.5×, beta 1.18, a −46% max drawdown history, and secular PC/print decline offset most of it.
Growth Quality
3 · Weak
Forward revenue CAGR ~2% (FY25 $55.3B → FY29E $60.7B). EPS grows faster (~9%/yr) but chiefly via buybacks, not unit growth. Gross margin only ~20%; ROIC is decent (~23%) but on a shrinking base.
Exponential Potential
1 · Very Low
PC and printing TAMs are flat-to-declining; units are down year over year. There is no acceleration and no room-to-run expansion — this is a cash-return name, definitionally not an exponential.
The three cases (our own scenario model — assumptions shown; each target is a ~12–18-month fair value). We deliberately do not attach probabilities: the base case is the expected path, so a weighted blend would just restate it with false precision.
Case
Key assumptions
Fair value
Bull
AI-PC refresh cycle lands; commodity/memory cost pressure eases; buybacks shrink share count. FY27E EPS ~$3.30 (top of range) on a modest re-rate to ~9.5×.
~$31 (+41%)
Base(our anchor)
Estimates roughly hit — FY27E EPS ~$3.05; a low-growth, high-FCF hardware name earns a ~8× multiple (roughly where it trades). Value realized mostly through dividend + buyback, not multiple expansion.
~$24 (+9%)
Bear
PC demand softens, supplies erosion accelerates, commodity/memory costs compress margins. FY26–27 EPS slips toward ~$2.50 and the multiple de-rates to ~6.5×.
~$16 (−27%)
Synthos fair value = the base case, ~$24 (+9%), with the full $16–$31 span as the honest range. Our base sits above the Street's $19.83 consensus (the Street's median target is actually below today's price — an unusually bearish tell for a Hold-rated name) because we give credit to the FCF/buyback floor; our bear takes the secular-decline case seriously. This is a tracked call — the Forecaster Scorecard grades it once it matures.
4. Exponential Potential
Synthos separates compounders (durable high returns on capital) from exponentials (accelerating, multi-baggers-from-here). HPQ is neither — it is a mature, ex-growth cash cow:
Forward growth: revenue CAGR FY25→FY29E ~2.4% ($55.3B → $60.7B). EPS CAGR ~9%, but decompose it: revenue is flat-ish, margins are flat, so the EPS growth is share-count reduction (946M diluted shares FY25, down from 1.42B in FY20 via buybacks).
Acceleration (2nd derivative): essentially zero / slightly negative. FY26E revenue growth ~4%, FY27E ~0%, FY28E ~0.3%. Total hardware units were down 7% in the latest quarter. There is no inflection to point to.
Room to run: the PC and printing TAMs are flat-to-shrinking, not expanding. Market cap $20B is small vs a mega-cap, but "room" requires a growing addressable market — HP's is contracting at the profitable (supplies) end.
Reinvestment runway: minimal. Capex is only ~1.4% of revenue; the company (rationally) returns cash rather than reinvesting for growth, because high-return growth projects are scarce.
Exponential Potential: Very Low (1/10). This is the honest floor of the scale — own HPQ, if at all, for dividend + buyback yield, never for compounding. Contrast with a genuine exponential (small, accelerating, TAM expanding): HPQ is the mirror image on all three axes.
Revenue: FY25 $55.30B, +3.2% (FY24 $53.56B; FY23 $53.72B). Roughly flat for three years; still below the FY21–22 COVID-PC peak ($63.5B / $62.9B). Latest quarters: Q1 FY26 $14.44B, Q2 FY26 $14.41B (+9.0% YoY) — a better-than-trend print, driven by Personal Systems +13%.
Margins (thin, hardware-typical): gross ~20% TTM, EBITDA margin ~6.8%, operating ~5.5%, net ~4.4%. Printing carries the profit (18.3% segment op margin) while Personal Systems runs ~5%.
Earnings: FY25 net income $2.53B, diluted EPS $2.65 (down from $2.81 FY24 as margins softened). TTM EPS ~$2.77.
Cash flow (the real story): FY25 operating CF $3.70B, capex only −$0.90B, FCF ~$2.80B — an ~14% FCF yield on market cap (FMP's TTM read is ~19%). This funds the dividend and buyback.
Capital returns: FY25 dividends −$1.09B + buybacks −$0.85B = ~$1.94B returned (~10% of market cap). Dividend yields ~5.4% and is ~43% of earnings — covered.
Balance sheet (the weak spot): total debt $10.9B, net debt $7.2B, net-debt/EBITDA ~1.5×. Total stockholders' equity is NEGATIVE (−$0.35B) — years of buybacks have driven book equity below zero, which makes ROE and P/B meaningless (FMP shows ROE −473% and P/B −140×; ignore both). Current ratio 0.79 (below 1) — HP runs on supplier financing (152 days payable vs 73 days inventory), normal for the model but leaves little slack.
6. Valuation — cheap for a reason?
HPQ is genuinely, unambiguously cheap on cash-flow metrics: 8.0× trailing EPS, 7.3× FY26E, 7.2× FY27E, EV/EBITDA 6.6×, EV/Sales 0.45×, ~14–19% FCF yield, 5.4% dividend. On a screen it looks like a deep-value bargain.
The catch is the classic value trap question: cheap for a reason. A ~2% grower in secularly declining end-markets, with a levered and negative-equity balance sheet, deserves a low-single-digit-teens multiple. The re-rating case rests on (a) the AI-PC refresh cycle actually lifting units and mix, and (b) continued aggressive buybacks compounding EPS on a low multiple. Neither is guaranteed; units are currently down.
Street targets (context, not our anchor): consensus $19.83, high $22, low $19 — the median target is below the current $21.93 price, and the grade distribution (1 Strong-Buy, 15 Buy, 28 Hold, 8 Sell) rounds to Hold. Our base FV of ~$24 is modestly above the Street because we credit the FCF/buyback floor, but we stop well short of "Buy" because there is no growth to underwrite and no expert conviction to lean on. Value, not quality; a Watch, not a Buy.
7. Technicals (from the tech block)
Trend: down. $21.93 sits below both the 50-DMA ($22.93) and 200-DMA ($22.69), and MACD is negative (−0.40). This is a downtrend, not an uptrend.
Location:−25% off the 52-week high ($29.35), +20% off the 52-week low ($18.20). The historical max drawdown from peak is −46% — this stock can and does fall hard.
Momentum: RSI(14) 22.6 — oversold (<30). That is a mean-reversion setup (not a trend confirmation): beaten-down names near RSI 23 sometimes bounce, but oversold in a downtrend is a falling-knife caveat, not an all-clear.
Relative strength (the tell): HPQ −14% 12-mo vs SPY +20.6% and QQQ +30.3% — massive underperformance of both the market and tech peers. Even 3-month (+15.7%) trails QQQ (+22.0%).
Read: technicals do not confirm a buy. A value-oriented buyer might view the oversold RSI as a lower-risk entry zone, but the primary trend is down and relative strength is poor. No urgency; patience is cheap here.
8. Moat & competitive position
HP's "moat" is modest and mostly in one place: the printing supplies annuity (installed-base lock-in on ink/toner, ~18% segment operating margin). That annuity is real but slowly eroding (third-party supplies, less printing, longer refresh). In Personal Systems, HP is a scale commodity assembler in a brutal, low-margin duopoly-plus market — pricing power is limited and units are cyclical. Switching costs are low; brand is decent but not decisive. Net: a narrow, eroding moat, concentrated in printing.
Peer set (FMP-supplied; a mixed hardware/IT-services basket, market cap): NetApp $30B, Teledyne $30B, Zoom $26B, Wipro $20B, Flex $50B, Broadridge $17B, Super Micro $18B, Leidos $14B, Logitech $13B, Rigetti $6B. This is not a clean comp set — HP's truest direct comps (Dell, Lenovo, Canon) aren't in the FMP list. Against this basket HPQ is among the cheapest on EV/EBITDA and highest on dividend yield, and among the lowest on growth — consistent with its value-not-growth profile.
9. Management, capital allocation & guidance
Capital allocation: disciplined and shareholder-friendly on the return side — ~$1.9B/yr back via dividend (5.4% yield, ~43% payout) and buyback, minimal capex. The critique is the flip side: buybacks have driven book equity negative and reduced financial flexibility while the core stagnates. It is a rational "harvest a mature business" posture, not a growth strategy.
Leadership:Bruce Broussard is Interim CEO per the FY26 Q2 release — a leadership transition is in progress, a governance item to watch.
Insider activity: the only open-market sale in the sampled window is the Chief Commercial Officer's 10,524 shares at $24.68 (filed 2026-06-16) — small and routine. Everything else is director RSU/stock awards (grants, not purchases). No cluster of alarming discretionary selling; no conviction insider buying either.
Management's own guidance (half-weighted — their self-interested words): the FY26 Q2 earnings release (SEC 8-K, filed 2026-05-27) provides real forward guidance, so we summarize it, labeled as management's own book:
- CFO Karen Parkhill: "strengthening our outlook for the fiscal year." Note the honest wrinkle: Q2 GAAP EPS ($0.49) came in below the prior guided $0.52–$0.58, even as non-GAAP ($0.86) beat — the GAAP/non-GAAP gap (~$0.40/yr of add-backs: restructuring, amortization, litigation) is wide and worth discounting. Management flagged rising commodity costs as a headwind. Guidance is management's self-interested framing; we half-weight it.
10. Catalysts & what to watch
Next earnings: 2026-08-26 (Q3 FY26; Street EPS $0.66, revenue ~$14.3B). Key lines: Personal Systems unit trend (units were −7%) and Printing supplies revenue (the margin annuity).
AI-PC refresh cycle: whether Windows-refresh + AI-PC upgrade actually lifts units and average selling prices in FY26–27 — the single biggest swing factor for the bull case.
Commodity / memory costs: management flagged rising costs pressuring margins; watch gross margin (~20%) for further erosion.
Buyback pace + dividend coverage: continued FCF ~$2.8–3.0B funding returns is the value floor.
CEO transition: resolution of the interim-CEO situation and any strategy shift.
Thesis tripwires (what would change the call): free cash flow falling below ~$2.5B (dividend-coverage risk); two more quarters of accelerating unit declines; gross margin breaking below ~19%; or the dividend being cut. Conversely, a durable AI-PC unit inflection plus sustained buybacks could move this from Watch toward Buy — Tactical.
11. Key risks
Secular decline (structural): PCs and printing are flat-to-shrinking end-markets; units are currently down. The whole business is a harvest, and harvests eventually run down.
Balance-sheet fragility: negative book equity, net-debt/EBITDA ~1.5×, current ratio 0.79 — little cushion if earnings dip. Buybacks have prioritized EPS optics over balance-sheet resilience.
Margin / commodity pressure: thin ~20% gross margin is sensitive to component/memory cost inflation (management-flagged) and FX; small moves swing EPS meaningfully.
Value trap: cheap can stay cheap for years absent a growth catalyst; the stock is already −14% over 12 months in a +21% market.
GAAP vs non-GAAP gap: headline EPS relies on ~$0.40/yr of add-backs; GAAP EPS is materially lower and recently missed guidance.
No expert coverage: the absence of any tracked bullish voice means there is no independent conviction backstopping the value case.
12. Verdict, position sizing & monitoring
Watch. HPQ is a real value/income situation — 8× earnings, ~14–19% FCF yield, 5.4% covered dividend, aggressive buyback — attached to a structurally challenged, ex-growth business with a levered, negative-equity balance sheet and no expert conviction in our KB. That combination doesn't clear our bar for "Buy," but the valuation and cash return are too tangible to call "Avoid." It sits squarely in Watch: know exactly what would move it (an AI-PC unit inflection, sustained FCF/buyback) and revisit on the print.
Sizing: if owned at all, small (~1–2%) as a deep-value / income sleeve position — never a core holding, never sized as a compounder. The oversold RSI (23) offers a tactical entry zone for value buyers, but the downtrend argues for patience.
Monitoring: re-underwrite on the §10 tripwires; formal re-score each earnings print. This verdict is logged as a tracked Synthos call as of 2026-07-03 at $21.93.
Single biggest risk: secular decline of the PC + printing franchises against a balance sheet with negative equity and no room for error.
Provenance & disclosures
Traceability:0 KB claims, breadth 0 — HPQ has no expert coverage in the Synthos knowledge base. This note carries no cited claim_ids because none exist; the verdict is explicitly fundamentals- and quant-driven. Fabricated conviction is structurally impossible (claim-ID reconciliation).
Data as-of: fundamentals 2026-04-30 (Q2 FY26) · estimates & prices 2026-07-02/03 · management guidance from the SEC 8-K earnings release filed 2026-05-27. Forward figures are analyst consensus (FMP) or management guidance, labeled as estimates.
Management caveat: HP's FY26 guidance (non-GAAP EPS $2.90–$3.10, FCF $2.8–$3.0B) is management's own, self-interested framing — half-weighted by design, and discounted further for the wide GAAP/non-GAAP gap.
Not investment advice. Independent research, educational and informational only, never personalized. Hypothetical/forward figures are labeled; the only performance numbers Synthos will headline are the live, real-money Flagship's.
Version: 2026-07-03. Prior versions available via the deep-dive version dropdown ("based on the info at the time").